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Zhang et al proinflammatory states. 6 Inflammatory and oxidative stress are related to the development of malignancy. 7, 8 Leptin (LEP) and LEP receptor (LEPR) may be implicated in various signal pathways, such as JAK/STAT, MAPK, PI3K, and mTOR. 9 Also, these signal pathways were suggested to be correlated with carcinogenesis. 10 , 11 Soga et al reported that fatty liver Shionogi-Lep/Lep mice developed hepatocellular adenomas and carcinomas following steatohepatitis. 12 In addition, high levels of LEP were found in sera of patients with HCC. 13 Thus, LEP and LEPR genes may impact on signal pathways and play an important role in the development of HCC.
Recently, some important LEP and LEPR single-nucleotide polymorphisms (SNPs) were explored for the susceptibility to a number of cancers. LEP rs7799039 A.G, a promoter SNP, was suggested this variant was particularly affecting transcriptional level and LEP expression.
14 However, LEP rs2167270 G.A is located in 5′-untranslated region and correlated with the translation process of LEP mRNA. Some previous metaanalyses suggested that LEP rs7799039 A.G and rs2167270 G.A variants conferred risk to cancer. [15] [16] [17] However, the association of LEP rs7799039 A.G and rs2167270 G.A polymorphisms with HCC risk is unknown.
LEPR rs1137100 G.A and rs1137101 G.A polymorphisms are two missense SNPs. Li et al reported that rs1137100 G.A and rs1137101 G.A polymorphisms in LEPR gene were correlated with susceptibility to HCC. 18 In individuals with chronic HBV infection, these two LEPR SNPs may be a biomarker for the susceptibility to HCC. 18 LEPR rs6588147 G.A is an intron SNP. Slattery et al found this SNP caused colon cancer susceptibility among men. 19 In view of these previous studies, we found that the relationship of LEP and LEPR polymorphisms with the development of cancer was unclear, especially in Asians. 20 In this study, we selected the LEP rs2167270 G.A, rs7799039 A.G, LEPR rs6588147 G.A, rs1137100 G.A, and rs1137101 G.A SNPs and conducted a case-control study to determine the relationship between LEP and LEPR polymorphisms and HCC risk in Eastern Chinese Han population.
Patients and methods subjects
This case-control study was performed on two groups. 
Dna extraction and genotyping
The blood sample obtained from each participant was stored at −80°C immediately. Promega Genomic DNA Kit (Promega Corporation, Fitchburg, WI, USA) was used to extract and purify genomic DNA from lymphocytes. Purity and concentration of genomic DNA were determined by the NanoDrop ND-1000 spectrophotometer and 1.5% agarose gel electrophoresis. SNPscan™ genotyping method (Genesky Biotechologies Inc., Shanghai, China) was used to determine LEP rs2167270 G.A, rs7799039 A.G, LEPR rs6588147 G.A, rs1137100 G.A, and rs1137101 G.A genotypes. Sixty sample sizes (4%) were randomly selected for quality control. The genotyping was performed by our technicians and the results were not changed.
statistical analysis
Data were analyzed by using SAS 9.4 software (SAS Institute, Cary, NC, USA). Continuous variables were expressed as mean±SD. Student's t-test was used to assess the differences in age distribution. Chi-square (χ 2 ) or Fisher's exact test was used to assess the distribution of age, sex, chronic HBV infection status, smoking status, alcohol use, and genotypes. The deviation from Hardy-Weinberg equilibrium in the control group was determined by using an online calculator (http://ihg.gsf.de/cgi-bin/hw/hwa1.pl) [21] [22] [23] [24] [25] to compare the observed genotype frequencies of LEP rs2167270 G.A, rs7799039 A.G, LEPR rs6588147 G.A, rs1137100 G.A, and rs1137101 G.A SNPs with the expected frequencies. Using additive, homozygote, dominant, and recessive models, the associations between LEP rs2167270 G.A, rs7799039 A.G, LEPR rs6588147 G.A, rs1137100 G.A, and rs1137101 G.A SNPs and susceptibility of HCC were assessed by crude/adjusted odds ratios (ORs) and confidence intervals (CIs). A P,0.05 (two-tailed) was considered as the threshold for statistical significance. In this study, a Bonferroni correction method was used for multiple testing.
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Results
Baseline characteristics
There were 584 HCC cases and 923 cancer-free controls included in our study. The frequency distributions for age, Table 1 . The characteristics of HCC cases and controls were fully matched by age and sex. The locus information of LEP rs2167270 G.A, rs7799039 A.G, LEPR rs6588147 G.A, rs1137100 G.A, and rs1137101 G.A polymorphisms is shown in Table 2 . The genotyping success rate for all SNPs was eligible (.99%). Minor allele frequency of these SNPs was similar to the data of Chinese population. For these included SNPs, the genotype distribution in controls conformed to Hardy-Weinberg equilibrium.
association of LEP rs2167270 g.a, rs7799039 a.g, LEPR rs6588147 g.a, rs1137100 g.a, and rs1137101 g.a polymorphisms with the risk of hcc Table 3 ).
Frequencies of LEPR rs6588147 GG, GA, and AA genotypes were 77.22%, 21.39%, and 1.39% in HCC patients and 71.77%, 26.71%, and 1.52% in controls, respectively. Table 3 ). However, we found no association between LEPR rs1137100 G.A and rs1137101 G.A polymorphisms and the risk of HCC in any genetic model (Table 3) . We used Bonferroni correction method to conduct a multiple testing. We found the genotype distribution of LEP rs7799039 A.G and LEPR rs6588147 G.A SNPs was still significantly different between HCC patients and cancer-free controls (P=0.006 and 0.007 for LEP rs7799039 A.G, and P=0.005 and 0.007 for LEPR rs6588147 G.A, respectively).
Discussion
Although chronic HBV infection status is associated with the etiology of HCC, the individual's hereditary factor may influence the susceptibility to HCC. Recently, it is believed that the metabolic disturbance increases the susceptibility to many malignancies. 4 Thus, the metabolism-related gene may affect the development of HCC. In this case-control study, we explored the relationship of LEP rs2167270 G.A, rs7799039 A.G, LEPR rs6588147 G.A, rs1137100 G.A, and rs1137101 G.A polymorphisms with the risk of HCC in 584 patients and 923 control subjects in Eastern Chinese Han population. We found that LEP rs7799039 A.G and rs2167270 G.A polymorphisms were associated with the susceptibility of HCC in this population. However, LEPR rs6588147 G.A polymorphism decreased the risk of HCC. To our knowledge, this is the study with the largest sample size on the relationship between LEP rs2167270 G.A, rs7799039 A.G, LEPR rs6588147 G.A, rs1137100 G.A, and rs1137101 G.A polymorphisms and HCC risk.
LEP rs7799039 A.G is a promoter SNP, which was suggested it could affect transcriptional level and LEP expression.
14 In this study, we found that LEP rs7799039 A.G polymorphism was associated with the susceptibility to HCC in Chinese Han population. Recently, a meta-analysis which included 16 published studies of 6,569 cancer cases and 8,405 controls demonstrated that LEP rs7799039 A.G polymorphism may decrease the risk of cancer. 20 In addition, this association between LEP rs7799039 A.G polymorphism and cancer risk was also found in other meta-analyses. 16, 17 However, the association between LEP rs7799039 A.G polymorphism and the risk of cancer was seldom studied in Asian populations. Clearly, these ambiguous findings suggested that the functions of LEP rs7799039 A.G variants might be different in different races. It was found that the minor allele frequency of LEP rs7799039 A.G polymorphism might alter sharply among different populations (0.201 [Chinese] vs 0.597 [Caucasians] ). 28 Recently, Romanowski et al reported that LEP rs2167270 G.A polymorphism increased the risk of posttransplant diabetes mellitus. 29 LEP rs2167270 G.A is located in 5′-untranslated region and may influence the translation process of LEP mRNA. A functional study demonstrated that serum LEP concentrations in LEP rs2167270 GA genotype were higher than in individuals with rs2167270 GG genotype. 30 In this study, the association between LEP rs2167270 G.A polymorphism and increased risk of HCC was found, which was very similar to the findings of the previous meta-analysis. 15 In the future, more casecontrol studies should be carried out to explore the potential association of LEP rs7799039 A.G and LEP rs2167270 G.A polymorphisms with cancer risk in Asians.
Slattery et al reported that LEPR rs6588147 AA genotype had a tendency to lower susceptibility of colon cancer in a mixed population. 19 We found that rs6588147 A allele may be associated with the decreased susceptibility of HCC, which was similar to previous findings. In our study, after Bonferroni correction test, this association was still significant between HCC patients and cancer-free controls. However, Nyante et al identified that the LEPR rs6588147 G.A polymorphism might confer susceptibility to breast cancer in luminal A subtype. 31 Only a few investigations focused on the correlation between LEPR rs6588147 G.A polymorphism and the risk of cancer, especially in Asians. In future, the association of this SNP with cancer susceptibility should be further studied with a large sample size. Also, functional studies are needed to identify the real biologic function of LEPR rs6588147 G.A polymorphism on the development of HCC.
There are some limitations in this study. First, since the number of HCC cases and controls was moderate, the power of study might be limited. Second, the HCC cases and controls were both enrolled from local hospitals. Therefore, selection bias should have occurred. Third, for lack of some important data, such as lifestyle, dietary habits, and environmental carcinogens exposure, the interaction of gene-environment was not studied. Fourth, the information available on HCC survival has been insufficient till now; thus, we could not further analyze the potential role of LEP/LEPR functional polymorphisms in HCC progression and prognosis. Fifth, due to lack of sufficient information on height and weight, the body mass index was not considered in this study. Finally, we only selected some functional SNPs in LEP and LEPR genes, and a fine-mapping or Genome Wide Association study focusing on LEP and LEPR genes should be performed to further explore the potential relationship of LEP and LEPR SNPs with the risk of HCC.
To sum up, this study has demonstrated that LEP rs7799039 A.G and rs2167270 G.A polymorphisms are genetic risk factors for HCC with various degrees of 
